Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Alcon Inc (NY: ALC )

85.74 -0.83 (-0.96%)
Official Closing Price Updated: 7:00 PM EST, Dec 12, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Alcon Inc

< Previous 1 2 3 Next >
Alcon Reports Third Quarter 2021 Results
From Alcon Inc. Investors
Via Business Wire
Alcon Unveils Latest Evolution of Cataract Integration and Connectivity at AAO 2021
From Alcon Inc. Corporate
Via Business Wire
Alcon to Acquire Ivantis, Inc. and its Hydrus Microstent for Surgical Glaucoma, Strengthening Global Ophthalmology Portfolio
From Alcon Inc. Investors
Via Business Wire
Alcon #Academy21 Program to Showcase TOTAL30, Other Innovations that Meet Critical Patient and Practice Needs
From Alcon Inc. Corporate
Via Business Wire
Alcon Celebrates World Sight Day 2021 in Communities Worldwide with Programs for Improved Access to Eye Care
From Alcon Inc. Corporate
Via Business Wire
Alcon Honored with FutureEdge 50 Award
From Alcon Inc. Corporate
Via Business Wire
Alcon Reports Second Quarter 2021 Results
From Alcon Inc. Investors
Via Business Wire
Alcon to Launch TOTAL30 as the First-and-Only Monthly Replacement, Water Gradient Contact Lens
From Alcon Inc. Investors
Via Business Wire
Alcon Reinforces Strength of Industry-Leading Ophthalmology Portfolio with Largest Surgical Device Scientific Presence at ASCRS 2021
From Alcon Inc. Investors
Via Business Wire
Alcon Announces Executive Committee Changes
From Alcon Inc. Investors
Via Business Wire
Alcon to Showcase Vision Care Innovation, Including Clinical Data for its Forthcoming Reusable Monthly Lens TOTAL30, at BCLA 2021
From Alcon Inc. Investors
Via Business Wire
Alcon Reports First Quarter 2021 Results
From Alcon Inc. Investors
Via Business Wire
Alcon to Acquire U.S. Commercialization Rights to Ophthalmic Eye Drop Simbrinza
From Alcon Inc. Investors
Via Business Wire
Alcon Shareholders Approve All Binding Resolutions at the 2021 Annual General Meeting
From Alcon Inc. Investors
Via Business Wire
Alcon Launches Systane Hydration Multi-Dose Preservative-Free Lubricant Eye Drops in the U.S.
From Alcon Inc. Investors
Via Business Wire
< Previous 1 2 3 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.